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      Dear  Sir: 
  We write to comment on the article by Humphries and oth-
ers  1   recently published in the   American Journal of Tropical 
Medicine and Hygiene  : in our opinion, the study is well con-
ducted, however, we respectfully disagree with the conclusions 
and in particular with the claim made by the authors about the 
failure of albendazole treatment of hookworms. 
  We summarize here the reasons of our disagreement: 
  Humphries and others base the claim for albendazole fail-
ure in treating hookworm infection on the analysis of   cure rate  
(CR) results that they measured at 61%; however, in the case of 
infections caused by hookworm and other soil-transmitted hel-
minths (STHs), the CR is not a good indicator of drug efficacy 
because it is influenced by the intensity of infection at base-
line and by the sensitivity of the parasitological method used 
to recover eggs from stool.  2   As a result, it is very difficult to 
compare CRs obtained in different settings and reach mean-
ingful conclusions about differences in drug efficacy. Our opin-
ion is that drug efficacy in STH infections should be assessed 
with a more apt indicator, namely the egg reduction rate 
(ERR). 
  The data presented by Humphries and others show an ERR 
of over 80% and this corresponds to the normal range of effi-
cacy of albendazole against this parasite,  3   as correctly reported 
by the authors. 
  We would also like to stress the fact that the main objective 
of preventive chemotherapy against hookworm and other STH 
infections (those by   Ascaris lumbricoides   and   Trichuris trichi-
ura  ) is not to achieve cure of infected individuals, but rather 
to significantly reduce the number of worms harbored by such 
individuals  4  ; this is because the average observed reduction 
(that can be measured by counting the number of eggs passed 
out in feces) is sufficient to cause the parallel decrease:
      ￿   of transmission (because of the reduced number of eggs 
contaminating the environment)  5 ;  and 
      ￿   of morbidity (because the few surviving worms—that can-
not replicate in the human host—cause less harm to the 
human host).  6     
  As an additional comment, we would also like to express 
our concern about the method used by the authors to assess 
drug quality (i.e.,   in vitro   anthelminthic activity), because this 
method has never been validated for albendazole that is insol-
uble in water; in addition, in our experience, the key factors 
in determining the quality of drugs used against STH are the 
tablet dissolution and disintegration times, and none of them 
was tested by the authors. 
  Finally, we strongly disagree with the authors’ statement 
that “  mebendazole and pyrantel are not any longer recom-
mended for the treatment of hookworm infection  ”; again, the 
studies on which the authors formulate their conclusion are 
based on the evaluation of the cure rate,  7,  8   and therefore, for 
the reasons mentioned previously, not conclusive. As a matter 
of fact, the World Health Organization (WHO) continues to 
include mebendazole and pyrantel in the list of recommended 
drugs for the treatment of STH infections. 
  The WHO is seriously concerned about unjustified claims 
of drug resistance made on the basis of incorrect interpre-
tations of parasitological results and on the poor under-
standing of the STH biology and control strategies. These 
claims create uncertainty among the managers of control 
programs about the efficacy of the control measures to be 
implemented and undermine the scaling up of STH control 
activities. 
  As a consequence, a working group reporting to the WHO 
Strategic and Technical Advisory Group on Neglected Tropical 
Diseases (NTD) was established with the aim of developing a 
Standard Operating Procedure to be implemented whenever 
a control manager suspects a reduction of the drug activity 
(report available at   http://www.who.int/neglected_diseases/
NTD_STAG_Report_2011.pdf ). 
  Although we hope that this much needed tool will be avail-
able before the end of the year, we take this opportunity to 
invite   AJTMH   and other scientific journals to carefully assess 
the grounds on which claims of drug failure are based should 
similar papers be submitted for publication. 
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